Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro
<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is a molecular complex tumor with high intrinsic drug resistance. Recent evidence suggests an involvement of the tyrosine kinase pathway in the regulation of ATP-binding cassette protein (ABC-transport...
Main Authors: | Hoffmann Katrin, Xiao Zhi, Franz Clemens, Mohr Elvira, Serba Susanne, Büchler Markus W, Schemmer Peter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/11/1/40 |
Similar Items
-
Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18–21 mutations
by: Nikolova Dafina, et al.
Published: (2022-09-01) -
HSP70–eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma
by: Meng Wang, et al.
Published: (2020-08-01) -
Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
by: Aswathy R. Devan, et al.
Published: (2021-07-01) -
Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9
by: Ghulam Mustafa, et al.
Published: (2023-04-01) -
The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma
by: Gian Paolo Caviglia, et al.
Published: (2021-03-01)